The crystalline form of 2-methyl-1 - [(4 - [6 - (trifluoromethyl) pyridine-2-il] - 6 - [(2 - (trifluoromethyl) pyridine-4-il) amino} - 1,3,5-cyano-2-il) amino] propane-2-o； the pharmaceutical components containing these substances are helpful for the preparation of useful drugs for the treatment of advanced blood tumors
Crystalline form of 1,3,5 - triazin isolated Compounds, substituted IDH2 inhibitors； and an advanced method to treat hematologic neoplasia selected acute myelogenous leukemia, myelodysplastic syndrome, Chronic myelocytic Leukemia, Myeloid Sarcoma, Multiple Myeloma and Lymphoma, defined P Or a Mutant allele of IDH2.Formas cristalinas de 2-metil-1-[(4-[6-(trifluorometil)piridin-2-il]-6-{[2-(trifluorometil)piridin-4-il]amino}-1,3,5-triazin-2-il)amino]propan-2-o； composición farmacéutica que las comprende, útiles en la preparación de un medicamento útil en el tratamiento de una neoplasia hematológica avanzada
